Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

NCT03604198 · clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
125
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Corcept Therapeutics